Carlene M M Lawes

Summary

Affiliation: University of Auckland
Country: New Zealand

Publications

  1. doi request reprint Statin use in COPD patients is associated with a reduction in mortality: a national cohort study
    Carlene M M Lawes
    Clinical Trials Research Unit, University of Auckland, Auckland, New Zealand
    Prim Care Respir J 21:35-40. 2012
  2. ncbi request reprint Blood pressure and the global burden of disease 2000. Part II: estimates of attributable burden
    Carlene M M Lawes
    Clinical Trials Research Unit, University of Auckland, Auckland, New Zealand
    J Hypertens 24:423-30. 2006
  3. ncbi request reprint Blood pressure and the global burden of disease 2000. Part 1: estimates of blood pressure levels
    Carlene M M Lawes
    Clinical Trials Research Unit, University of Auckland, Auckland, New Zealand
    J Hypertens 24:413-22. 2006
  4. ncbi request reprint Blood pressure indices and cardiovascular disease in the Asia Pacific region: a pooled analysis
    Carlene M M Lawes
    Clinical Trials Research Unit, University of Auckland, Private Bag 92019, Auckland, New Zealand
    Hypertension 42:69-75. 2003
  5. ncbi request reprint Blood pressure and stroke: an overview of published reviews
    Carlene M M Lawes
    Clinical Trials Research Unit, Department of Medicine, University of Auckland, Auckland, New Zealand
    Stroke 35:776-85. 2004
  6. ncbi request reprint Blood pressure and stroke: an overview of published reviews
    Carlene M M Lawes
    Clinical Trials Research Unit, Department of Medicine, University of Auckland, Auckland, New Zealand
    Stroke 35:1024. 2004
  7. ncbi request reprint Blood pressure and coronary heart disease: a review of the evidence
    Carlene M M Lawes
    Clinical Trials Research Unit, Department of Medicine, University of Auckland, New Zealand
    Semin Vasc Med 2:355-68. 2002
  8. ncbi request reprint Smoking and elevated blood pressure are the most important risk factors for subarachnoid hemorrhage in the Asia-Pacific region: an overview of 26 cohorts involving 306,620 participants
    Valery Feigin
    Department of Medicine and School of Population Health, Faculty of Medicine and Health Sciences, University of Auckland, Auckland, New Zealand
    Stroke 36:1360-5. 2005
  9. ncbi request reprint Risk factors for subarachnoid hemorrhage: an updated systematic review of epidemiological studies
    Valery L Feigin
    Clinical Trials Research Unit, Faculty of Medicine and Health Sciences, University of Auckland, Auckland, New Zealand
    Stroke 36:2773-80. 2005
  10. doi request reprint Attention deficits after incident stroke in the acute period: frequency across types of attention and relationships to patient characteristics and functional outcomes
    Suzanne L Barker-Collo
    Department of Psychology, University of Auckland, Auckland, New Zealand
    Top Stroke Rehabil 17:463-76. 2010

Detail Information

Publications27

  1. doi request reprint Statin use in COPD patients is associated with a reduction in mortality: a national cohort study
    Carlene M M Lawes
    Clinical Trials Research Unit, University of Auckland, Auckland, New Zealand
    Prim Care Respir J 21:35-40. 2012
    ..To assess whether statin use is associated with reduced mortality in patients with chronic obstructive pulmonary disease (COPD)...
  2. ncbi request reprint Blood pressure and the global burden of disease 2000. Part II: estimates of attributable burden
    Carlene M M Lawes
    Clinical Trials Research Unit, University of Auckland, Auckland, New Zealand
    J Hypertens 24:423-30. 2006
    ..To provide estimates of the global burden of disease attributable to non-optimal blood pressure by age and sex for adults aged > or = 30 years, by WHO subregion...
  3. ncbi request reprint Blood pressure and the global burden of disease 2000. Part 1: estimates of blood pressure levels
    Carlene M M Lawes
    Clinical Trials Research Unit, University of Auckland, Auckland, New Zealand
    J Hypertens 24:413-22. 2006
    ..To provide global estimates of blood pressure by age and sex for adults aged > or = 30 years, by WHO subregion...
  4. ncbi request reprint Blood pressure indices and cardiovascular disease in the Asia Pacific region: a pooled analysis
    Carlene M M Lawes
    Clinical Trials Research Unit, University of Auckland, Private Bag 92019, Auckland, New Zealand
    Hypertension 42:69-75. 2003
    ..These data suggest that if time or resources are highly constrained, such as in much-needed epidemiologic surveys in developing countries, very little is lost from only measuring SBP...
  5. ncbi request reprint Blood pressure and stroke: an overview of published reviews
    Carlene M M Lawes
    Clinical Trials Research Unit, Department of Medicine, University of Auckland, Auckland, New Zealand
    Stroke 35:776-85. 2004
    ..This article provides an overview of published reviews of the effects on stroke seen in trials of BP-lowering drugs and compares these with the results available from cohort studies...
  6. ncbi request reprint Blood pressure and stroke: an overview of published reviews
    Carlene M M Lawes
    Clinical Trials Research Unit, Department of Medicine, University of Auckland, Auckland, New Zealand
    Stroke 35:1024. 2004
    ..This article provides an overview of published reviews of the effects on stroke seen in trials of BP-lowering drugs and compares these with the results available from cohort studies...
  7. ncbi request reprint Blood pressure and coronary heart disease: a review of the evidence
    Carlene M M Lawes
    Clinical Trials Research Unit, Department of Medicine, University of Auckland, New Zealand
    Semin Vasc Med 2:355-68. 2002
    ..Finally, and most importantly, the large majority of people have suboptimal blood pressure (e.g., systolic > 115 mm Hg) and so initiatives to lower blood pressure population-wide are an essential adjunct to targeted treatment programs...
  8. ncbi request reprint Smoking and elevated blood pressure are the most important risk factors for subarachnoid hemorrhage in the Asia-Pacific region: an overview of 26 cohorts involving 306,620 participants
    Valery Feigin
    Department of Medicine and School of Population Health, Faculty of Medicine and Health Sciences, University of Auckland, Auckland, New Zealand
    Stroke 36:1360-5. 2005
    ....
  9. ncbi request reprint Risk factors for subarachnoid hemorrhage: an updated systematic review of epidemiological studies
    Valery L Feigin
    Clinical Trials Research Unit, Faculty of Medicine and Health Sciences, University of Auckland, Auckland, New Zealand
    Stroke 36:2773-80. 2005
    ..After a 1996 review from our group on risk factors for subarachnoid hemorrhage (SAH), much new information has become available. This article provides an updated overview of risk factors for SAH...
  10. doi request reprint Attention deficits after incident stroke in the acute period: frequency across types of attention and relationships to patient characteristics and functional outcomes
    Suzanne L Barker-Collo
    Department of Psychology, University of Auckland, Auckland, New Zealand
    Top Stroke Rehabil 17:463-76. 2010
    ..Attention deficits are common post stroke and result in poorer functional outcomes. This study examined the frequency of attention deficits after incident stroke and their correlates...
  11. doi request reprint Neuropsychological profiles of 5-year ischemic stroke survivors by Oxfordshire stroke classification and hemisphere of lesion
    Suzanne Barker-Collo
    Department of Psychology, The University of Auckland, Private Bag 92019, Auckland, New Zealand
    Stroke 43:50-5. 2012
    ..This article examined profiles of cognitive function by hemisphere and by Oxfordshire Community Stroke Project stroke classification...
  12. ncbi request reprint Treatment with drugs to lower blood pressure and blood cholesterol based on an individual's absolute cardiovascular risk
    Rod Jackson
    Section of Epidemiology and Biostatistics, School of Population Health, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand
    Lancet 365:434-41. 2005
    ..An affordable daily pill combining low doses of various drugs could be useful for the many individuals with slightly abnormal cardiovascular risk factors...
  13. doi request reprint Global burden of blood-pressure-related disease, 2001
    Carlene M M Lawes
    Clinical Trials Research Unit, University of Auckland, Auckland, New Zealand
    Lancet 371:1513-8. 2008
    ..Few studies have assessed the extent and distribution of the blood-pressure burden worldwide. The aim of this study was to quantify the global burden of disease related to high blood pressure...
  14. ncbi request reprint Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century
    Valery L Feigin
    Department of Medicine, Faculty of Medicine and Health Sciences, University of Auckland, Auckland, New Zealand
    Lancet Neurol 2:43-53. 2003
    ....
  15. ncbi request reprint Mortality attributable to higher-than-optimal body mass index in New Zealand
    Cliona Ni Mhurchu
    Public Health Intelligence Unit, Ministry of Health, Wellington, New Zealand
    Public Health Nutr 8:402-8. 2005
    ..To estimate the burden of mortality in New Zealand due to higher-than-optimal body mass index (BMI) in 1997, as well as mortality that could be avoided in 2011 with feasible changes in mean population BMI...
  16. doi request reprint Reducing attention deficits after stroke using attention process training: a randomized controlled trial
    Suzanne L Barker-Collo
    Clinical Training Programme, Department of Psychology Tamaki Campus, Faculty of Science, University of Auckland, Auckland, New Zealand
    Stroke 40:3293-8. 2009
    ..There was no evidence for effectiveness of APT in stroke patients. This trial evaluated effectiveness of APT in improving attention and broader outcomes in stroke survivors 6 months after stroke...
  17. ncbi request reprint The Perindopril Protection Against Recurrent Stroke Study (PROGRESS): clinical implications for older patients with cerebrovascular disease
    Yogini Ratnasabapathy
    Clinical Trials Research Unit, University of Auckland, Auckland, New Zealand
    Drugs Aging 20:241-51. 2003
    ....
  18. ncbi request reprint Estimating energy expenditure with the RT3 triaxial accelerometer
    Ralph Maddison
    Clinical Trials Research Unit, University of Auckland, New Zealand
    Res Q Exerc Sport 80:249-56. 2009
    ..The RT3 provided a relatively accurate assessment of free-living activity-related energy expenditure at the group level and generally underestimated total and activity-related energy expenditure compared to DLW..
  19. doi request reprint No effect of ultraviolet radiation on blood pressure and other cardiovascular risk factors
    Robert Scragg
    Epidemiology and Biostatistics, School of Population Health, University of Auckland, Auckland, New Zealand
    J Hypertens 29:1749-56. 2011
    ..The study aim is to determine if exposure to ultraviolet B radiation, which synthesizes vitamin D, lowers blood pressure, compared with ultraviolet A radiation...
  20. ncbi request reprint Ethnic disparity of pancreatic cancer in New Zealand
    Anthony R J Phillips
    Department of Surgery, Faculty of Medical and Health Science, University of Auckland, Auckland, New Zealand
    Int J Gastrointest Cancer 31:137-45. 2002
    ..The etiology of pancreatic cancer remains elusive. Identification of high-risk groups may enable targeted study to identify new markers and risk factors...
  21. pmc Rethinking the "diseases of affluence" paradigm: global patterns of nutritional risks in relation to economic development
    Majid Ezzati
    Harvard School of Public Health, Boston, Massachusetts, USA
    PLoS Med 2:e133. 2005
    ....
  22. doi request reprint Cigarette smoking, systolic blood pressure, and cardiovascular diseases in the Asia-Pacific region
    Koshi Nakamura
    Nutrition and Lifestyle Division, The George Institute for International Health, PO Box M201, Missenden Road, Camperdown, NSW 2050, Australia
    Stroke 39:1694-702. 2008
    ..If these 2 risk factors have a synergistic impact on cardiovascular events, lowering BP and quitting smoking will contribute more to reducing CVD than would be expected from ignoring their interaction...
  23. ncbi request reprint Hypertension: its prevalence and population-attributable fraction for mortality from cardiovascular disease in the Asia-Pacific region
    Alexandra L C Martiniuk
    The George Institute for International Health at the University of Sydney, Australia
    J Hypertens 25:73-9. 2007
    ....
  24. ncbi request reprint Global and regional mortality from ischaemic heart disease and stroke attributable to higher-than-optimum blood glucose concentration: comparative risk assessment
    Goodarz Danaei
    Harvard School of Public Health, Boston, MA 02115, USA
    Lancet 368:1651-9. 2006
    ..We aimed to quantify population-level effects of all higher-than-optimum concentrations of blood glucose on mortality from ischaemic heart disease and stroke worldwide...
  25. ncbi request reprint Cardiovascular mortality attributable to high blood cholesterol in New Zealand
    Maria L Turley
    Public Health Intelligence, Ministry of Health, Wellington, New Zealand
    Aust N Z J Public Health 30:252-7. 2006
    ....
  26. ncbi request reprint Nutrition and the burden of disease in New Zealand: 1997-2011
    Niki Stefanogiannis
    Public Health Intelligence, Ministry of Health, PO Box 5013, Wellington, New Zealand
    Public Health Nutr 8:395-401. 2005
    ....
  27. ncbi request reprint Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular-disease risk
    Christopher J L Murray
    Evidence and Information for Policy, World Health Organization, 27, Geneva, Switzerland
    Lancet 361:717-25. 2003
    ....